AKT1 and cancer: Numerous studies have indicated that alterations in the ErbB receptor are linked to various cancers, with EGFR directly regulating phosphatidylinositol 3‐kinase/protein kinase B (PI3K/Akt) (Androutsopoulos et al., 2023; Ding et al., 2021).